EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

Alberto F Sobrero, Joan Maurel, Louis Fehrenbacher, Werner Scheithauer, Yousif A Abubakr, Manfred P Lutz, M Eugenia Vega-Villegas, Cathy Eng, Ernst U Steinhauer, Jana Prausova, Heinz-Josef Lenz, Christophe Borg, Gary Middleton, Hendrik Kröning, Gabriele Luppi, Oliver Kisker, Angela Zubel, Christiane Langer, Justin Kopit, Howard A Burris

Research output: Contribution to journalArticlepeer-review

769 Citations (Scopus)

Fingerprint

Dive into the research topics of 'EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences